However, when we analyzed binding of NHP-B2 multimer in animals that failed to reject 291PC cells (NR) compared to lymphoma survivors (LS), we observed a significant difference in multimer-binding capacity of CD8+ T-cells (p=0.022, Figure 5C). The gene discussed is CD8A; the disease is lymphoma.